NCT03623126View on ClinicalTrials.gov

Impact of ESSURE Devices Withdrawal on the Symptomatology of Patients

CompletedOBSERVATIONAL
Enrollment

41

Participants

Timeline

Start Date

August 8, 2018

Primary Completion Date

September 3, 2018

Study Completion Date

September 3, 2018

Conditions
Quality of LifeContraceptive Device; Complications
Interventions
OTHER

Questionnaire

A questionnaire to evaluate clinical improvement and quality of life after ESSURE removal will be completed by patients at least one month after the procedure.

Trial Locations (2)

60495

Service de Gynécologie-Obstétrique - Centre Hospitalier Lyon Sud, Pierre-Bénite

69004

Service de gynécologie-Obstétrique - Hôpital de la Croix Rousse, Lyon

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT03623126 - Impact of ESSURE Devices Withdrawal on the Symptomatology of Patients | Biotech Hunter | Biotech Hunter